Aleor Dermaceuticals receives EIR for Karakhadi formulations facility in Gujarat
Alembic Pharmaceuticals announced that Aleor Dermaceuticals, a 60:40 Joint Venture between Alembic Pharmaceuticals (Alembic) and Orbicular Pharmaceutical Technologies (Orbicular), has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the inspection carried out by them at Aleor's Formulation Facility at Karakhadi, Gujarat, India during the
period from 15 September, 2019 to 20 September, 2019.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 18 2019 | 1:54 PM IST